Neighbourhood social participation and women's use of anxiolytic-hypnotic drugs: A multilevel analysis

Journal of Epidemiology and Community Health

Volumn 58, Issue 1, 2004, Pages 59-64

  Johnell, K ^a   Merlo, J ^b   Lynch, J ^c   Blennow, G ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MICHIGAN   (United States)

^d National Social Insurance Board   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; HYPNOTIC AGENT;

DRUG USER; NEIGHBORHOOD; WOMENS STATUS;

ADULT; AGED; COMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISABILITY; DRUG UTILIZATION; EDUCATION; FEMALE; HEALTH; HUMAN; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METHODOLOGY; PENSION; PREVALENCE; PROBABILITY; QUANTITATIVE ANALYSIS; RATING SCALE; REVIEW; SAMPLE; SOCIAL INTERACTION; STRESS; SWEDEN;

AGED; ANTI-ANXIETY AGENTS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH BEHAVIOR; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MIDDLE AGED; PROSPECTIVE STUDIES; SOCIAL ENVIRONMENT; SOCIAL SUPPORT; SWEDEN;

EURASIA; EUROPE; MALMO; NORTHERN EUROPE; SCANDINAVIA; SKANE; SWEDEN;

EID: 0346725915     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.58.1.59     Document Type: Review

References (29)

1. Imanaka Y, Araki S, Nobutomo K. Effects of patient health beliefs and satisfaction on compliance with medication regimens in ambulatory care at general hospitals. Nippon Eiseigaku Zasshi 1993;48:601-11.
2. Isacson D, Haglund B. Psychotropic drug use in a Swedish community - the importance of demographic and socioeconomic factors. Soc Sci Med 1988;26:477-83.
3. Haaijer-Ruskamp FM, Hemminki E. The social aspects of drug use. WHO Reg Publ Eur Ser 1993;45:97-124.
4. Ashton H, Golding JF. Tranquillisers: prevalence, predictors and possible consequences. Data from a large United Kingdom survey. Br J Addict 1989;84:541-6.
5. Emmons KM. Health behaviors in a social context. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York: Oxford University Press, 2000:242-66.
6. Macintyre S, Ellaway A. Ecological approaches: rediscovering the role of the physical and social environment. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York: Oxford University Press, 2000:332-48.
7. Groenewegen PP, Leufkens HG, Spreeuwenberg P, et al. Neighbourhood characteristics and use of benzodiazepines in the Netherlands. Soc Sci Med 1999;48:1701-11.
8. Woolcock M, Deepa N. Social capital: implications for development theory, research and policy. World Bank Res Obs 1999;Feb.
9. Kawachi I, Berkman LF. Social cohesion, social capital, and health. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York: Oxford University Press, 2000:174-90.
10. Berkman LF. Assessing social networks and social support in epidemiologic studies. Rev Epidemiol Sante Publique 1987;35:46-53.
11. Berglund G, Elmstahl S, Janzon L, et al. The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 1993;233:45-51.
12. Merlo J, Berglund G, Wirfalt E, et al. Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol 2000;152:788-92.
13. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. (http://www.whocc.no/atcddd/).
14. Capella D. Descriptive tools and analysis. WHO Reg Publ Eur Ser 1993;45:55-78.
15. Sweden Statistics. Living conditions. Isolation and togetherness - an outlook on social participation 1976, Report no 18. Stockholm: Sweden Statistics, 1980.
16. Snijders T, Bosker R. Multilevel analysis - an introduction to basic and advanced multilevel modeling. Thousand Oaks, CA: Sage, 1999.
17. Rice N, Leyland A. Multilevel models: applications to health data. J Health Serv Res Policy 1996;1:154-64.
18. Leyland A, Goldstein H. Multilevel modelling of health statistics. Chichester: Wiley, 2001.
19. Goldstein H, Browne W, Rasbash J. Partitioning variation in multilevel models. London: Multilevel Models Project, Institute of Education, (http:// multilevel.ioe.ac.uk/team/materials/pvmm.pdf).
20. Browne W, Subramanian S, Jones K, et al. Variance partitioning in multilevel logistic models that exhibit over-dispersion. London: Multilevel Models Project, Institute of Education, (http://multilevel.ioe.ac.uk/team/ materials/ vpmlmeo.pdf).
21. Rasbosh J, Browne W, Goldstein H, et al. A user's guide to MLwiN. Version 2.1. London: Multilevel Models Project, Institute of Education, University of London, 2000.
22. Lindstrom M, Merlo J, Ostergren PO. Individual and neighbourhood determinants of social participation and social capital: a multilevel analysis of the city of Malmo. Sweden, Soc Sci Med 2002;54:1779-91.
23. Melander A, Henricson K, Stenberg P, et al. Anxiolytic-hypnotic drugs: relationships between prescribing, abuse and suicide. Eur J Clin Pharmacol 1991;41:525-9.
24. Ukoumunne OC, Gulliford MC, Chinn S, et al. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess 1999;3:iii-92.
25. Manjer J, Carlsson S, Elmstahl S, et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001;10:489-99.
26. Hanson BS, Ostergren PO, Elmstahl S, et al. Reliability and validity assessments of measures of social networks, social support and control - results from the Malmo Shoulder and Neck Study. Scand J Soc Med 1997;25:249-57.
27. Merlo J, Lynch J, Yang M, et al. Effect of neighborhood social participation on individual use of hormone replacement therapy and anti-hypertensive medication: a multilevel analysis. Am J Epidemiol 2003;157:774-83.
28. Kaplan GA. What is the role of the social environment in understanding inequalities in health? Ann N Y Acad Sci 1999;896:116-19.
29. Merlo J. Multilevel analytical approaches in social epidemiology: measures of health variation compared with traditional measures of association. J Epidemiol Community Health 2003;57:550-2.